NCBiotech’s Flash Grant program aims to identify and energize the most creative ideas that exhibit early indications of commercial potential. Like a flash of inspiration, Flash Grants infuse funding at a critical early point when a small, targeted influx of funds can be crucial to shaping innovative research ideas into high potential life sciences technologies, particularly in emerging and converging life sciences sectors.
Flash Grants are used to demonstrate the disruptive potential of a technology or to move a technology into the translational research phase of development.
For fiscal year 2021, there will be three submission cycles for the Flash Grant program. Cycle-specific guidelines will be posted prior to each deadline.
Cycle 1: Deadline Wednesday, August 12, 2020 (noon)
- Novel antibiotics and therapeutics targeting antibiotic-resistant bacteria
- Global Coronavirus disease (COVID-19) outbreak - COVID-19-specific therapies, vaccine development, diagnosis, and epidemiology
Cycle 2: Deadline Wednesday, November 11, 2020 (noon)
- Topics to be determined (posted by late September, 2020)
Cycle 3: Deadline Wednesday, March 10, 2021 (noon)
- Open round; all topics with some restrictions
Applicant organizations must be universities or non-profit research institutions. Companies are not eligible to apply for Flash Grant awards.
FY21 Cycle 1 Flash Grant program materials are posted below. The online application form will be available on the Portal by July 12, 2020.
How to Submit your Proposal:
Important First Step: The Principal Investigator for the proposal must register for an account on the NCBiotech Funding Portal in advance of the deadline in order submit a proposal.
Click here for instructions and more information.
Maximum Award: $20,000
Wednesday, August 12, 2020 (noon)
Targeted Solicitation (see guidelines)
Wednesday, November 11, 2020 (noon)
Targeted Solicitation (topics TBD)
Wednesday, March 10, 2021 (noon)